These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10111761)

  • 1. AIDS and FDA drug-approval policy: an evolving controversy.
    Gould SJ
    J Health Soc Policy; 1990; 2(2):39-46. PubMed ID: 10111761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
    Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
    Lovell MC
    Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
    [No Abstract]   [Full Text] [Related]  

  • 4. Great expectations: is the U.S. doing its best to beat AIDS?. Interview by Don McLearn.
    Parkman PD
    FDA Consum; 1989 Feb; 23(1):36-8. PubMed ID: 10312853
    [No Abstract]   [Full Text] [Related]  

  • 5. The "treatment IND (investigational new drugs)": public policy considerations.
    Roberts C; Palumbo FB
    J Pharm Mark Manage; 1988; 3(1):41-59. PubMed ID: 10290888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational new drug regs: icing or cake?
    Margolis RE
    Healthspan; 1988 Dec; 5(11):25-6. PubMed ID: 10291398
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug approval and AIDS: benefits for the elderly.
    Rothman DJ; Edgar H
    Health Aff (Millwood); 1990; 9(3):123-30. PubMed ID: 2227773
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AIDS epidemic and clinical trials.
    Young FE
    Acad Med; 1989 Nov; 64(11):660-1. PubMed ID: 2803424
    [No Abstract]   [Full Text] [Related]  

  • 12. New rules for new drugs: the challenge of AIDS to the regulatory process.
    Edgar H; Rothman DJ
    Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game.
    Begley S; Hager M; Wilson L
    Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942
    [No Abstract]   [Full Text] [Related]  

  • 14. Policy statement on FDA reform. Food and Drug Administration.
    Baker R; Delaney M; Getty J; Grinberg L; Levin J
    BETA; 1995 Sep; ():45-6. PubMed ID: 11362893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA reforms drug approval system.
    Hayes AH
    US Med; 1983 Jan; 19(2):41-2. PubMed ID: 10259319
    [No Abstract]   [Full Text] [Related]  

  • 16. The fast track: federal agencies and the political demand for AIDS drugs.
    Foreman CH
    Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
    [No Abstract]   [Full Text] [Related]  

  • 17. The challenge of regulating development and approval of drugs with pleiotropic action in cardiovascular disease.
    Temple R
    Am J Cardiol; 1998 Apr; 81(8A):5F-9F. PubMed ID: 9604896
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 19. Methodological issues in AIDS clinical trials. Statutory and regulatory framework for drug approval.
    Burlington DB
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S4-9. PubMed ID: 2231300
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanded availability of investigational new drugs through a parallel track mechanism for people with AIDS and other HIV-related disease--PHS. Notice final policy statement.
    Fed Regist; 1992 Apr; 57(73):13250-9. PubMed ID: 10118459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.